Potassium%2525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte used to prevent or treat hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. ## Adult Dosing * **Oral Prevention:** 20-40 mEq daily, divided into 1-2 doses. * **Oral Treatment:** 40-100 mEq daily, divided into 2-4 doses. Maximum dose typically 100 mEq/day. * **Intravenous Treatment:** Varies based on severity of hypokalemia and clinical status. Usual rate of infusion is 10-20 mEq/hour. Maximum concentration typically 40 mEq/L, and maximum infusion rate 20 mEq/hour, unless severe, life-threatening hypokalemia in a monitored setting (may go up to 40 mEq/hour with cardiac monitoring). **Specific IV dosing and infusion rates should follow local hospital protocol or physician order.** ## Pediatric Dosing * **Oral Prevention:** 1-2 mEq/kg/day, maximum 3 mEq/kg/day or 100 mEq/day. * **Oral Treatment:** 2-5 mEq/kg/day, divided into 2-4 doses. Maximum dose typically 100 mEq/day. * **Intravenous Treatment:** 0.5-1 mEq/kg/dose, maximum 20 mEq/dose. Infusion rate typically 0.3-1 mEq/kg/hour, not to exceed 20 mEq/hour. **Specific IV dosing and infusion rates should follow local hospital protocol or physician order.** ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Dose reduction is usually necessary, and monitoring of potassium levels is critical. ## Contraindications * Hyperkalemia. * Conditions leading to increased potassium levels (e.g., severe renal impairment, untreated Addison's disease, acute dehydration, extensive tissue breakdown). ## Adverse Effects * **Common:** Nausea, vomiting, abdominal pain, diarrhea. * **Serious:** Hyperkalemia (most significant risk), cardiac arrhythmias, cardiac arrest, gastrointestinal ulceration, bleeding, or perforation. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride):** Increased risk of hyperkalemia. * **ACE inhibitors and ARBs (e.g., lisinopril, losartan):** Increased risk of hyperkalemia. * **NSAIDs (e.g., ibuprofen, naproxen):** Can reduce potassium excretion, increasing risk of hyperkalemia. * **Digoxin:** Hyperkalemia can potentiate digoxin toxicity. Hypokalemia can increase the risk of digoxin toxicity. ## Monitoring * Serum potassium levels: Frequently, especially with IV administration or in patients with renal impairment. * Renal function (BUN, creatinine). * ECG: In cases of rapid IV infusion or suspected hyperkalemia. * Signs and symptoms of hypokalemia and hyperkalemia. ## Clinical Pearls * Oral potassium chloride tablets can be irritating to the gastrointestinal tract; always administer with food or meals. * Do not crush or chew extended-release formulations. * IV potassium chloride should be diluted. Never administer as a bolus. * Monitor IV sites closely for infiltration or phlebitis, as extravasation can cause tissue damage. *** *Disclaimer: This information is intended for educational purposes and does not substitute for professional medical advice. Always consult the most current prescribing information and guidelines for complete details on indications, contraindications, warnings, precautions, adverse effects, drug interactions, and dosing. Verify all information with current product labeling and consult with a qualified healthcare provider before making any treatment decisions.*